Literature DB >> 18638568

Sphingosine 1-phosphate chemical biology.

Kevin R Lynch1, Timothy L Macdonald.   

Abstract

A dozen years ago, the term 'S1P' (sphingosine 1-phosphate) was not in the lexicons of scientific literature databases. By early 2008, this query term retrieved well over 1000 citations from PubMed - about 225 of these appeared in 2007. Indeed, S1P is arguably the most heavily studied lipid molecule at present. What happened to distinguish S1P among many other signaling lipids? We believe that the seminal event was the linking of the investigational drug, FTY720 (fingolimod), to S1P signaling. This realization profoundly altered understanding of S1P biology, revealing both that S1P is prominent in lymphocyte trafficking and that mimicking S1P signaling with an agonist drug can modulate the immune system to considerable therapeutic benefit. Neither fact was known prior to FTY720; indeed, this molecule is testament to the power of chemical biology. In this communication, we attempt to summarize progress to date in S1P chemical biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638568      PMCID: PMC3412363          DOI: 10.1016/j.bbalip.2008.06.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  67 in total

1.  Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients.

Authors:  Susan R Schwab; João P Pereira; Mehrdad Matloubian; Ying Xu; Yong Huang; Jason G Cyster
Journal:  Science       Date:  2005-09-09       Impact factor: 47.728

2.  Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.

Authors:  Kenneth LaMontagne; Amanda Littlewood-Evans; Christian Schnell; Terence O'Reilly; Lorenza Wyder; Teresa Sanchez; Beatrice Probst; Jeannene Butler; Alexander Wood; Gene Liau; Eric Billy; Andreas Theuer; Timothy Hla; Jeanette Wood
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.

Authors:  Rainer Albert; Klaus Hinterding; Volker Brinkmann; Danilo Guerini; Constanze Müller-Hartwieg; Helmut Knecht; Corinne Simeon; Markus Streiff; Trixie Wagner; Karl Welzenbach; Frédéric Zécri; Markus Zollinger; Nigel Cooke; Eric Francotte
Journal:  J Med Chem       Date:  2005-08-11       Impact factor: 7.446

Review 4.  Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease.

Authors:  S-K Jo; A Bajwa; A S Awad; K R Lynch; M D Okusa
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

5.  Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.

Authors:  Sindy H Wei; Hugh Rosen; Melanie P Matheu; M Germana Sanna; Sheng-Kai Wang; Euijung Jo; Chi-Huey Wong; Ian Parker; Michael D Cahalan
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

6.  Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720.

Authors:  Yugesh Kharel; Sangderk Lee; Ashley H Snyder; Stacey L Sheasley-O'neill; Margaret A Morris; Yulius Setiady; Ran Zhu; Molly A Zigler; Tracy L Burcin; Klaus Ley; Kenneth S K Tung; Victor H Engelhard; Timothy L Macdonald; Sonia Pearson-White; Kevin R Lynch
Journal:  J Biol Chem       Date:  2005-08-10       Impact factor: 5.157

7.  Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.

Authors:  Zhen Li; Weirong Chen; Jeffrey J Hale; Christopher L Lynch; Sander G Mills; Richard Hajdu; Carol Ann Keohane; Mark J Rosenbach; James A Milligan; Gan-Ju Shei; Gary Chrebet; Stephen A Parent; James Bergstrom; Deborah Card; Michael Forrest; Elizabeth J Quackenbush; L Alexandra Wickham; Hugo Vargas; Rose M Evans; Hugh Rosen; Suzanne Mandala
Journal:  J Med Chem       Date:  2005-10-06       Impact factor: 7.446

8.  Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.

Authors:  Barbara Zemann; Bernd Kinzel; Matthias Müller; Roland Reuschel; Diana Mechtcheriakova; Nicole Urtz; Frédéric Bornancin; Thomas Baumruker; Andreas Billich
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

9.  Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway.

Authors:  Shizhong Bu; Bagrat Kapanadze; Tien Hsu; Maria Trojanowska
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

10.  Antinociceptive activity of the S1P-receptor agonist FTY720.

Authors:  Ovidiu Coste; Sandra Pierre; Claudiu Marian; Christian Brenneis; Carlo Angioni; Helmut Schmidt; Laura Popp; Gerd Geisslinger; Klaus Scholich
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

View more
  12 in total

1.  Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.

Authors:  Perry C Kennedy; Ran Zhu; Tao Huang; Jose L Tomsig; Thomas P Mathews; Marion David; Olivier Peyruchaud; Timothy L Macdonald; Kevin R Lynch
Journal:  J Pharmacol Exp Ther       Date:  2011-06-01       Impact factor: 4.030

2.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

3.  Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS.

Authors:  Laura J Sim-Selley; Paulette B Goforth; Mba U Mba; Timothy L Macdonald; Kevin R Lynch; Sheldon Milstien; Sarah Spiegel; Leslie S Satin; Sandra P Welch; Dana E Selley
Journal:  J Neurochem       Date:  2009-05-31       Impact factor: 5.372

Review 4.  Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering.

Authors:  Bernard Y K Binder; Priscilla A Williams; Eduardo A Silva; J Kent Leach
Journal:  Tissue Eng Part B Rev       Date:  2015-07-14       Impact factor: 6.389

5.  Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors.

Authors:  Thomas P Mathews; Andrew J Kennedy; Yugesh Kharel; Perry C Kennedy; Oana Nicoara; Manjula Sunkara; Andrew J Morris; Brian R Wamhoff; Kevin R Lynch; Timothy L Macdonald
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

6.  The sphingosine 1-phosphate receptor, S1PR₁, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons.

Authors:  Xian Xuan Chi; G D Nicol
Journal:  J Neurophysiol       Date:  2010-09-15       Impact factor: 2.714

7.  Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion.

Authors:  J Hunter Mehaffey; Eric J Charles; Adishesh K Narahari; Sarah Schubert; Victor E Laubach; Nicholas R Teman; Kevin R Lynch; Irving L Kron; Ashish K Sharma
Journal:  J Thorac Cardiovasc Surg       Date:  2018-03-11       Impact factor: 5.209

8.  Delivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect.

Authors:  Anusuya Das; Shaun Tanner; Daniel A Barker; David Green; Edward A Botchwey
Journal:  J Biomed Mater Res A       Date:  2013-10-17       Impact factor: 4.396

Review 9.  Sphingosine lysolipids in the CNS: endogenous cannabinoid antagonists or a parallel pain modulatory system?

Authors:  Dana E Selley; Sandra P Welch; Laura J Sim-Selley
Journal:  Life Sci       Date:  2013-06-16       Impact factor: 5.037

Review 10.  Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation.

Authors:  David J Swan; John A Kirby; Simi Ali
Journal:  J Cell Mol Med       Date:  2010-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.